diabetes

Stem cells for Diabetes: the danger of the word ‘cure’

Stem-cell-Diabetes-Hype

There has been considerable discussion about the whether the media hyped the recent Harvard stem cells for diabetes paper (see top 10 takeaways of that paper). I believe that this was greatly hyped. This Harvard publication reported production of insulin-secreting cells from human embryonic stem cells (hESC). Newspapers around the world widely exaggerated the potential impact …

Stem cells for Diabetes: the danger of the word ‘cure’ Read More »

Takeaways From Harvard Stem Cells for Diabetes Paper

Harvard-stem-cells-Diabetes

The idea of using stem cells for treat Type I Diabetes is very promising and could have huge practical impact. Real progress has been achieved toward this goal over the last decade. In perhaps another decade there might be a validated treatment. A new stem cell paper has just come out in Cell from Harvard in this …

Takeaways From Harvard Stem Cells for Diabetes Paper Read More »

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product

ViaCyte-logo-3x2

Type 1 Diabetes is a huge global problem. Where are the solutions that would compliment or replace insulin therapy for diabetics? There haven’t been too many that have gotten very far, which makes the news of a potential stem cell-based therapy moving along in the pipeline all the more exciting. ViaCyte (see more posts here, …

Great News: FDA Nod For ViaCyte IND of Diabetes Stem Cell-Based Product Read More »

More on Betatrophin, my take on the Cell paper, and a video

Melton-Peng-Yi-300x1861

I finally got a chance to read the Cell paper by the Melton team on Betatrophin and it is quite cool. Update — Unfortunately the Betatrophin paper discussed here originally back in 2013 has now largely been proven to have come to incorrect conclusions (for more read this). I think one big question is whether …

More on Betatrophin, my take on the Cell paper, and a video Read More »